The original content of Democracy Now! Headlines appears under the Creative
Commons BY-NC-ND 3.0 License (United States). For more, including their other
shows and media, visit www.democracynow.org.
November 5, 2013

Johnson & Johnson to Pay $2.2 Billion to Settle Fraud Charges 
--------------------------------------------------------------


 
The pharmaceutical giant Johnson & Johnson has agreed to pay $2.2
billion to settle a long-running probe into its marketing of drugs for
unapproved uses. Johnson & Johnson, and subsidiary Janssen, promoted the
anti-psychotic drug Risperdal for treating anxiety in elderly dementia
patients and behavior problems in children. The company also
acknowledged paying kickbacks to Omnicare, the country's largest
pharmacy serving nursing home patients. The $2.2 billion fine marks one
of the largest healthcare fraud settlements in U.S. history.

 

.